Cargando…
CARs—A New Perspective to HCMV Treatment
Human cytomegalovirus (HCMV), by primary infection or reactivation, represents a great risk for immune-suppressed or compromised patients. In immunocompetent humans, the immune system suppresses the spread of HCMV during an infection, resulting in a mostly asymptomatic or mild course of the disease,...
Autores principales: | Bednar, Christopher, Ensser, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402902/ https://www.ncbi.nlm.nih.gov/pubmed/34452428 http://dx.doi.org/10.3390/v13081563 |
Ejemplares similares
-
HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
por: Collins-McMillen, Donna, et al.
Publicado: (2018) -
Re-Analysis of the Widely Used Recombinant Murine Cytomegalovirus MCMV-m157luc Derived from the Bacmid pSM3fr Confirms Its Hybrid Nature
por: Cordsmeier, Arne, et al.
Publicado: (2023) -
Insight for Immunotherapy of HCMV Infection
por: Long, Xinmiao, et al.
Publicado: (2021) -
A Genetically Encoded Dark-to-Bright Biosensor for Visualisation of Granzyme-Mediated Cytotoxicity
por: Bednar, Christopher, et al.
Publicado: (2023) -
HCMV latency: what regulates the regulators?
por: Elder, Elizabeth, et al.
Publicado: (2019)